查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617847

感染控制市場：按傳播方式、產品和最終用戶分類 - 2025-2030 年全球預測

Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年感染控制市場價值為436.2億美元，預計到2024年將達到457.9億美元，複合年成長率為5.23%，到2030年將達到623.6億美元。

感染控制包括旨在減少感染傳播的各種政策和程序，特別是在醫療機構中，以保護患者和醫護人員。其範圍從醫院和診所延伸到社區健康和住宅護理設施等其他場所，使其成為醫療保健服務的重要方面。在 COVID-19 大流行期間，透過加強手部衛生、消毒、疫苗接種和使用個人防護工具等措施，控制感染的必要性變得更加明顯。研究應用涵蓋各種最終用途部門，包括醫院、門診手術中心和實驗室。全球感染控制市場的主要成長決定因素包括醫療保健相關感染（HAI）盛行率的上升、滅菌和消毒技術的進步、感染預防意識的提高和政府舉措以及老年護理服務，其中包括老年人口的增加。存在巨大的商機，包括對一次性醫用不織布、智慧感染控制管理系統的需求激增，以及提供相關感染控制建議的遠端醫療服務的擴展。然而，該市場面臨一些挑戰，例如實施先進感染控制系統的高成本、不同地區的監管要求以及缺乏訓練有素的專業人員（尤其是在新興國家）。專注於抗菌塗層儀器、自動滅菌系統和用於感染風險評估的資料驅動預測分析的創新可能會推動業務的顯著成長。目前，在公共衛生緊迫性和技術創新的推動下，市場充滿活力，但隨著世界對感染預防意識的增強，競爭也越來越嚴重。利用技術改進，同時解決成本和培訓限制，可以為感染控制解決方案的有效性和可近性帶來正面的結果。對於策略性業務營運，與將人工智慧和物聯網整合到感染預防和控制中的科技公司合作可以提供競爭優勢。

主要市場統計
基準年[2023] 436.2億美元
預計年份 [2024] 457.9億美元
預測年份 [2030] 623.6億美元
複合年成長率（%） 5.23%

市場動態：揭示快速發展的感染控制市場的關鍵市場洞察

供需的動態交互作用正在改變感染控制市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 醫院感染發生率上升和感染控制產品的快速使用
    • 手術數量的增加以及對適當安全方法的需求
    • 感染控制產品在醫療設備和製藥業的快速採用
  • 市場限制因素
    • 與化學消毒劑相關的副作用
  • 市場機會
    • 醫院和診所增加滅菌服務外包
    • 製造商增加生產感染控制產品的投資
  • 市場挑戰
    • 感染控制替代產品和技術的可用性

波特五力：駕馭感染控制市場的策略工具

波特的五力框架是了解感染控制市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解感染控制市場的外部影響

外部宏觀環境因素在塑造感染控制市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解感染控制市場的競爭格局

對感染控制市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣感染控制市場供應商的績效評估

FPNV 定位矩陣是評估感染控制市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了感染控制市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，感染控制市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫院感染發生率上升和感染控制產品的快速使用
      • 外科手術的增加和採取適當安全措施的必要性
      • 感染控制產品在醫療設備和製藥業的快速採用
    • 抑制因素
      • 與化學消毒劑相關的副作用
    • 機會
      • 醫院和診所增加滅菌服務外包
      • 製造商增加感染控制產品生產的投資
    • 任務
      • 替代感染控制產品和技術的可用性
  • 市場區隔分析
    • 產品：滅菌的使用正在迅速增加，以通過去除包括孢子在內的所有形式的微生物來確保醫療設備的安全。
    • 最終使用者：不斷發展醫院和診所部門感染控制的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 感染控制市場傳播

  • 空氣
  • 血源性的
  • 合約

第7章感染控制市場：依產品

  • 清潔消毒
    • 消毒劑
      • 乾洗手劑
      • 器械消毒劑
      • 皮膚消毒劑
      • 表面消毒劑
    • 裝置
      • 閃光消毒裝置
      • 超音波清洗機
      • 紫外線消毒器
      • 清洗消毒機
    • 處方
      • 消毒噴霧
      • 消毒紙巾
      • 液體消毒劑
    • 消毒等級
      • 進階
      • 中級
      • 低級
  • 內視鏡再處理
    • 消耗品
    • 裝置
  • 防護屏障
    • 蓋和封閉
    • 風鏡
    • 醫用不織布
  • 消毒
    • 電子束滅菌
    • 設備滅菌
    • 環氧乙烷滅菌
    • 過濾除菌
    • 伽瑪射線滅菌
    • 放射線殺菌
    • 蒸氣滅菌

第8章感染控制市場：依最終用戶分類

  • 食品和飲料公司
  • 醫院/診所
  • 生命科學產業
  • 醫療設備公司
  • 製藥公司

第9章美洲感染控制市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太感染控制市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲感染控制市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 科德寶醫療在哥斯大黎加建立第二個生產工廠
    • WPT 非織造佈公司在肯塔基州製造工廠投資 1,950 萬美元，以促進當地經濟
    • Berry 推出了輕型管封閉解決方案，符合感染控制通訊協定規定的嚴格安全和衛生標準。
  • 戰略分析和建議

公司名單

  • 3M Company
  • Abbott Laboratories
  • AliMed, Inc.
  • Amway Corporation
  • Ansell Ltd.
  • ASP International GmbH
  • Becton, Dickinson and Company
  • Belimed AG
  • bioMerieux SA
  • Cantel Medical Group
  • Cardinal Health Inc.
  • Codi Group BV
  • Colgate-Palmolive Company
  • Dandong Huayang Textile and Garment Co., Ltd.
  • Diversey Holdings Ltd.
  • Ecolab Corporation
  • Embuer Health Pvt. Ltd.
  • Essity AB
  • F. Hoffmann-La Roche Ltd.
  • Getinge AB
  • Go Green Solutions, LLC
  • GOJO Industries, Inc.
  • Hartmann Group
  • Jiaxing Hongjie Commodity Co., Ltd.
  • Kao Corporation
  • Kimberly-Clark Corporation
  • Matachana Group
  • Medexter Healthcare GmbH
  • Medline Industries, LP
  • MELAG Medizintechnik GmbH & Co. KG
  • Merck KGaA
  • Metrex Research, LLC
  • Nice-Pak Products, Inc.
  • Olympus Corporation
  • Pal International Ltd.
  • Pfizer Inc.
  • Procter & Gamble Company
  • Professional Disposables International, Inc.
  • Reckitt Benckiser Group PLC
  • Rockline Industries Ltd.
  • SC Johnson & Son, Inc.
  • Sotera Health LLC
  • Sterigenics International LLC
  • Steris Corporation
  • Unicharm Corporation
  • Unilever PLC
  • Weiman Products, LLC
  • World Precision Instruments, LLC
  • Yessor Wipes
Product Code: MRR-43676CF42B0E

The Infection Control Market was valued at USD 43.62 billion in 2023, expected to reach USD 45.79 billion in 2024, and is projected to grow at a CAGR of 5.23%, to USD 62.36 billion by 2030.

Infection control encompasses a range of policies and procedures aimed at inhibiting the spread of infections, especially in healthcare facilities, to protect both patients and healthcare workers. It's a critical dimension of healthcare services, with its scope extending from hospitals and clinics to other environments like community healthcare and residential care facilities. The necessity of infection control became even more pronounced during the COVID-19 pandemic, reinforcing practices like hand hygiene, sterilization, vaccination, and the use of personal protective equipment. Applications span across diverse end-use sectors, including hospitals, ambulatory surgical centers, research laboratories, and more. Key growth determinants for the global infection control market include the rising prevalence of healthcare-associated infections (HAIs), advancements in sterilization and disinfection technologies, heightened awareness and governmental initiatives for infection prevention, and an increased elderly population requiring aged care services. There are significant opportunities such as the surge in demand for single-use medical nonwovens, smart infection control management systems, and the expansion of telemedicine services that offer curated infection control advice. However, the market faces challenges like high costs related to implementing advanced infection control systems, variations in regulatory requirements across regions, and an inadequate number of trained professionals, particularly in developing countries. Innovations concentrated on antimicrobial-coated devices, automated sterilization systems, and data-driven predictive analytics for infection risk assessment could catalyze substantial business growth. The market is currently dynamic, being driven by both public health urgencies and technological innovations, but competition is intensifying as global awareness about infection prevention amplifies. Addressing limitations related to cost and training while capitalizing on technology enhancements can yield positive outcomes in both efficacy and accessibility of infection control solutions. For strategic business maneuvers, collaboration with tech companies to integrate AI and IoT in infection prevention and control may offer competitive advantages.

KEY MARKET STATISTICS
Base Year [2023] USD 43.62 billion
Estimated Year [2024] USD 45.79 billion
Forecast Year [2030] USD 62.36 billion
CAGR (%) 5.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infection Control Market

The Infection Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of hospital-acquired infections and surging usage of infection control products
    • Increasing number of surgical procedures and need for appropriate safety methods
    • Upsurging adoption of infection control products in medical device and pharmaceutical industry
  • Market Restraints
    • Adverse effects associated with chemical based disinfectants
  • Market Opportunities
    • Increasing outsourcing of sterilization services by hospitals, and clinics
    • Growing investments by manufacturers in the production of infection control products
  • Market Challenges
    • Availability of substitute products and techniques for infection control

Porter's Five Forces: A Strategic Tool for Navigating the Infection Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infection Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infection Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infection Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infection Control Market

A detailed market share analysis in the Infection Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infection Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infection Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infection Control Market

A strategic analysis of the Infection Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Transmission, market is studied across Airborne, Bloodborne, and Contract.
  • Based on Products, market is studied across Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers, and Sterilization. The Cleaning & Disinfection is further studied across Disinfectants, Equipment, Formulation, and Level of Disinfection. The Disinfectants is further studied across Hand Disinfectants, Instrument Disinfectants, Skin Disinfectants, and Surface Disinfectants. The Equipment is further studied across Flusher Disinfectors, Ultrasonic Cleaners, UV-Ray Disinfectors, and Washer Disinfectors. The Formulation is further studied across Disinfectant Sprays, Disinfectant Wipes, and Liquid Disinfectants. The Level of Disinfection is further studied across High-Level, Intermediate-Level, and Low-Level. The Endoscope Reprocessing is further studied across Consumables and Equipment. The Protective Barriers is further studied across Covers & Closures, Goggles, and Medical Nonwovens. The Sterilization is further studied across E-Beam Sterilization, Equipment Sterilization, ETO Sterilization, Filtration Sterilization, Gamma Sterilization, Radiation Sterilization, and Steam Sterilization.
  • Based on End-User, market is studied across Food & Beverage Companies, Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
      • 5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
      • 5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with chemical based disinfectants
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
      • 5.1.3.2. Growing investments by manufacturers in the production of infection control products
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of substitute products and techniques for infection control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
    • 5.2.2. End-User: Evolving usage of infection control in hospitals & clinics sector
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infection Control Market, by Transmission

  • 6.1. Introduction
  • 6.2. Airborne
  • 6.3. Bloodborne
  • 6.4. Contract

7. Infection Control Market, by Products

  • 7.1. Introduction
  • 7.2. Cleaning & Disinfection
    • 7.2.1. Disinfectants
      • 7.2.1.1. Hand Disinfectants
      • 7.2.1.2. Instrument Disinfectants
      • 7.2.1.3. Skin Disinfectants
      • 7.2.1.4. Surface Disinfectants
    • 7.2.2. Equipment
      • 7.2.2.1. Flusher Disinfectors
      • 7.2.2.2. Ultrasonic Cleaners
      • 7.2.2.3. UV-Ray Disinfectors
      • 7.2.2.4. Washer Disinfectors
    • 7.2.3. Formulation
      • 7.2.3.1. Disinfectant Sprays
      • 7.2.3.2. Disinfectant Wipes
      • 7.2.3.3. Liquid Disinfectants
    • 7.2.4. Level of Disinfection
      • 7.2.4.1. High-Level
      • 7.2.4.2. Intermediate-Level
      • 7.2.4.3. Low-Level
  • 7.3. Endoscope Reprocessing
    • 7.3.1. Consumables
    • 7.3.2. Equipment
  • 7.4. Protective Barriers
    • 7.4.1. Covers & Closures
    • 7.4.2. Goggles
    • 7.4.3. Medical Nonwovens
  • 7.5. Sterilization
    • 7.5.1. E-Beam Sterilization
    • 7.5.2. Equipment Sterilization
    • 7.5.3. ETO Sterilization
    • 7.5.4. Filtration Sterilization
    • 7.5.5. Gamma Sterilization
    • 7.5.6. Radiation Sterilization
    • 7.5.7. Steam Sterilization

8. Infection Control Market, by End-User

  • 8.1. Introduction
  • 8.2. Food & Beverage Companies
  • 8.3. Hospitals & Clinics
  • 8.4. Life Sciences Industry
  • 8.5. Medical Device Companies
  • 8.6. Pharmaceutical Companies

9. Americas Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Freudenberg Medical Establishes Second Production Facility In Costa Rica
    • 12.3.2. WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy
    • 12.3.3. Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. AliMed, Inc.
  • 4. Amway Corporation
  • 5. Ansell Ltd.
  • 6. ASP International GmbH
  • 7. Becton, Dickinson and Company
  • 8. Belimed AG
  • 9. bioMerieux SA
  • 10. Cantel Medical Group
  • 11. Cardinal Health Inc.
  • 12. Codi Group BV
  • 13. Colgate-Palmolive Company
  • 14. Dandong Huayang Textile and Garment Co., Ltd.
  • 15. Diversey Holdings Ltd.
  • 16. Ecolab Corporation
  • 17. Embuer Health Pvt. Ltd.
  • 18. Essity AB
  • 19. F. Hoffmann-La Roche Ltd.
  • 20. Getinge AB
  • 21. Go Green Solutions, LLC
  • 22. GOJO Industries, Inc.
  • 23. Hartmann Group
  • 24. Jiaxing Hongjie Commodity Co., Ltd.
  • 25. Kao Corporation
  • 26. Kimberly-Clark Corporation
  • 27. Matachana Group
  • 28. Medexter Healthcare GmbH
  • 29. Medline Industries, LP
  • 30. MELAG Medizintechnik GmbH & Co. KG
  • 31. Merck KGaA
  • 32. Metrex Research, LLC
  • 33. Nice-Pak Products, Inc.
  • 34. Olympus Corporation
  • 35. Pal International Ltd.
  • 36. Pfizer Inc.
  • 37. Procter & Gamble Company
  • 38. Professional Disposables International, Inc.
  • 39. Reckitt Benckiser Group PLC
  • 40. Rockline Industries Ltd.
  • 41. S. C. Johnson & Son, Inc.
  • 42. Sotera Health LLC
  • 43. Sterigenics International LLC
  • 44. Steris Corporation
  • 45. Unicharm Corporation
  • 46. Unilever PLC
  • 47. Weiman Products, LLC
  • 48. World Precision Instruments, LLC
  • 49. Yessor Wipes

LIST OF FIGURES

  • FIGURE 1. INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFECTION CONTROL MARKET DYNAMICS
  • TABLE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SINGAPORE INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 220. SINGAPORE INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 221. SINGAPORE INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 232. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 241. TAIWAN INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 242. TAIWAN INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 243. TAIWAN INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 244. TAIWAN INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 245. TAIWAN INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 252. THAILAND INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 253. THAILAND INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 254. THAILAND INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. THAILAND INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 256. THAILAND INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 257. THAILAND INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. VIETNAM INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 264. VIETNAM INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 265. VIETNAM INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 266. VIETNAM INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 267. VIETNAM INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 268. VIETNAM INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 269. VIETNAM INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. DENMARK INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 287. DENMARK INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 288. DENMARK INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 289. DENMARK INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 290. DENMARK INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 291. DENMARK INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 292. DENMARK INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 293. DENMARK INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 294. DENMARK INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 297. EGYPT INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 298. EGYPT INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 299. EGYPT INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 300. EGYPT INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 301. EGYPT INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 302. EGYPT INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 303. EGYPT INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 304. EGYPT INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 305. EGYPT INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 307. FINLAND INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 308. FINLAND INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 309. FINLAND INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 310. FINLAND INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 311. FINLAND INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 312. FINLAND INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 313. FINLAND INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 314. FINLAND INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 315. FINLAND INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 316. FINLAND INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 317. FRANCE INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 318. FRANCE INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 319. FRANCE INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 320. FRANCE INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 321. FRANCE INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 322. FRANCE INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 323. FRANCE INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 324. FRANCE INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 325. FRANCE INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 326. FRANCE INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 327. FRANCE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 328. GERMANY INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 329. GERMANY INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 330. GERMANY INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 331. GERMANY INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 332. GERMANY INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 333. GERMANY INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 334. GERMANY INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 335. GERMANY INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 336. GERMANY INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 337. GERMANY INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 338. GERMANY INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 339. ISRAEL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 340. ISRAEL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 341. ISRAEL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 342. ISRAEL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 343. ISRAEL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 344. ISRAEL INFECTION CONTROL M